Skip to main content
logo
Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
214.00
-0.65 (-0.30%)
At close: Oct 23, 2026, 4:00 PM EDT
214.20
+0.20 (0.09%)
After-hours: Oct 23, 2026, 7:44 PM EDT

Jazz Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
4,6014,2684,0693,8343,6593,094
Revenue Growth
12.59%4.88%6.12%4.78%18.26%30.91%
Gross Profit
4,2033,9123,7583,5503,3922,877
Operating Income
1,2091,018864.14816.23839.14475.26
Net Income
940.75-356.15560.12414.83-224.06-329.67
Earnings Per Share
14.63-5.848.656.10-3.58-5.52
EPS Growth
--41.75%---

Revenue by Segment
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Neuroscience
3,0492,8782,6982,7082,7612,335
Total Oncology
1,3211,1291,1111,015873.84733.81
Other Product
-14.1711.4713.856.649.8
High-Sodium Oxybate AG Royalty
187.14211.73217.5875.92--
Other Royalty and Contract
35.8334.0130.2121.3417.9515.24
Revenue (Total)
4,6014,2684,0693,8343,6593,094

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2,2002,4422,9941,630881.48591.45
Total Debt
4,4095,4276,1675,8005,8176,174
Net Cash (Debt)
-2,210-2,985-3,173-4,170-4,936-5,583
Net Cash Growth
------
Net Cash Per Share
-34.35-48.96-48.07-57.86-78.92-93.53

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1,6611,3561,3961,0921,272778.51
Capital Expenditures
-69.75-58.75-38.07-23.96-29.05-27.64
Free Cash Flow
1,5911,2971,3581,0681,243750.87
Free Cash Flow Growth
25.79%-4.48%27.13%-14.07%65.53%-15.12%

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
91.35%91.67%92.36%92.59%92.70%92.97%
Operating Margin
26.28%23.86%21.24%21.29%22.93%15.36%
Pretax Margin
15.81%-14.73%11.52%7.69%-10.46%-3.67%
Profit Margin
20.45%-8.34%13.77%10.82%-6.12%-10.65%
FCF Margin
34.58%30.39%33.37%27.86%33.97%24.27%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
14.62-13.2918.67--
Forward PE
10.387.675.726.298.548.23
P/FCF Ratio
8.737.965.487.258.0710.43
PS Ratio
3.022.421.832.022.742.53